Creates breakthrough medical devices that treat numerous cardiovascular diseases
HeartPoint Global Ireland Ltd. (A subsidiary of HeartPoint Global Inc.) creates breakthrough medical devices that treat numerous cardiovascular diseases that affect tens of millions of people across the globe. HPG’s mission is to bring innovative medical devices to the developed and the developing world’s populations that would otherwise suffer from or die of cardiovascular diseases.
The HeartPoint Global Implant System (HPG-IS), HPG’s first product, is the first-and-only patented, non-surgical, medical device system that allows bi-directional adjustment of blood flow in the cardio-pulmonary system at any time during and after device deployment. The HPG-IS will bring cost effective, minimally-invasive alternatives to cardio-vascular surgeries and therapies.